Company profile: Tahoe Bio
1.1 - Company Overview
Company description
- Provider of AI-powered tools that simulate human cell responses to guide drug discovery, including Mosaic for generating large-scale single-cell datasets and high-resolution in vivo phenotypic and transcriptomic profiling, single-cell RNA pooling to analyze drug action across diverse patients, and in vivo drug-cell interaction studies; initial applications in oncology; open-sources the Tahoe-100M dataset.
Products and services
- In vivo drug-cell interaction studies: An in vivo program that interrogates drug-cell interactions within living organisms to uncover mechanisms of action and resistance not detectable in vitro, revealing biological effects missed by cell-culture assays
- Mosaic: A large-scale platform producing high-resolution in vivo single-cell datasets that capture phenotypic and transcriptomic cell-state changes to determine drug efficacy and gene expression in diverse cells, initially applied to oncology
- Single-cell RNA profiling: A pooled-sample single-cell RNA method that aggregates cells from diverse patients into one tumor to analyze drug action across many patients in a single experiment, exposing patient-diversity in response
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tahoe Bio
OmniSeq
HQ: United States
Website
- Description: Provider of genomic and immune tumor profiling solutions, offering OmniSeq INSIGHT for all solid tumors and research services including gene expression analysis, TCRβ repertoire profiling, PDL-1 IHC, transcriptome sequencing, and genome/exome sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniSeq company profile →
Forte Research
HQ: United States
Website
- Description: Provider of clinical and translational research management software, offering OnCore and Clinical Conductor CTMS for operational, financial, analytics, regulatory, and recruitment needs at academic medical centers, cancer centers, health systems, hospitals, and research sites; plus Advarra eReg, eSource + EDC, eConsent, and Secure Document Exchange for compliant data capture and secure e-regulatory document workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Forte Research company profile →
rMark Bio
HQ: United States
Website
- Description: Provider of intelligence solutions to the life science industry through Fabric, a patented intelligence platform that unites real-time pharmaceutical business objectives with the activities of academic and clinical researchers to deliver next best decisions, remove inefficiencies, and increase ROI in thought leader engagements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full rMark Bio company profile →
AltaVoice
HQ: United States
Website
- Description: Provider of patient-centered data services that build and host Patient Insights Networks (PINs) to collect, curate, and share patient and clinician reported health data, working with drug developers to optimize the search for better treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AltaVoice company profile →
System Analytic
HQ: United Kingdom
Website
- Description: Provider of an ecosystem of innovative digital tools and world-class services to support the entire KOL/HCP engagement cycle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full System Analytic company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tahoe Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tahoe Bio
2.2 - Growth funds investing in similar companies to Tahoe Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tahoe Bio
4.2 - Public trading comparable groups for Tahoe Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →